| Q34344700 | A role of autophagy in PTP4A3-driven cancer progression. |
| Q37299613 | Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment |
| Q64103536 | Autophagy inhibition enhances PD-L1 expression in gastric cancer |
| Q38034270 | Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity |
| Q38670616 | Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells |
| Q34662185 | Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation. |
| Q24307941 | Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates |
| Q30513775 | Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy |
| Q93164897 | Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy |
| Q30585666 | Competing targets of microRNA-608 affect anxiety and hypertension. |
| Q43698158 | Development of a novel ovarian cancer molecular target therapy against cancer-related transcriptional factor, NAC1. |
| Q35852880 | Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy |
| Q37733036 | Downregulation of miR-429 contributes to the development of drug resistance in epithelial ovarian cancer by targeting ZEB1. |
| Q36733968 | Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis |
| Q36954314 | Effect of taxol on the expression of FoxM1 ovarian cancer-associated gene |
| Q39011282 | Exogenous high-mobility group box 1 inhibits apoptosis and promotes the proliferation of lewis cells via RAGE/TLR4-dependent signal pathways |
| Q38868212 | Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance |
| Q36089961 | Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas |
| Q22676705 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) |
| Q34622835 | HMGB1 in health and disease |
| Q38203471 | HMGB1 in hormone-related cancer: a potential therapeutic target |
| Q34344751 | HMGB1-dependent and -independent autophagy |
| Q41136849 | HMGB1: A Promising Therapeutic Target for Prostate Cancer |
| Q26774902 | High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer |
| Q34129779 | High mobility group box 1 (HMGB1) phenotypic role revealed with stress |
| Q47152534 | High mobility group protein B1 is a predictor of poor survival in ovarian cancer. |
| Q28395154 | Hydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stress |
| Q37415453 | Identification of the NAC1-regulated genes in ovarian cancer |
| Q33563929 | Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas |
| Q38152325 | Involvement of autophagy in cervical, endometrial and ovarian cancer |
| Q36562901 | Life after death: targeting high mobility group box 1 in emergent cancer therapies |
| Q27311277 | Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axis |
| Q43044672 | Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies. |
| Q98612910 | MiR-218-5p Suppresses the Progression of Retinoblastoma Through Targeting NACC1 and Inhibiting the AKT/mTOR Signaling Pathway |
| Q35763174 | MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy |
| Q26765417 | Molecular mechanisms for synergistic effect of proteasome inhibitors with platinum-based therapy in solid tumors |
| Q91928711 | Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma |
| Q36170245 | NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells. |
| Q49879368 | NAC1 promotes the migration of prostate cancer cells and participates in osteoclastogenesis by negatively regulating IFNβ. |
| Q58702494 | NACC1, as a Target of MicroRNA-331-3p, Regulates Cell Proliferation in Urothelial Carcinoma Cells |
| Q41911962 | NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy |
| Q33713849 | Nac1 interacts with the POZ-domain transcription factor, Miz1. |
| Q41471207 | Nac1 promotes self-renewal of embryonic stem cells through direct transcriptional regulation of c-Myc. |
| Q39214221 | Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells |
| Q41042814 | Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification |
| Q41193919 | Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1α axis. |
| Q42546855 | Overexpression of NAC1 confers drug resistance via HOXA9 in colorectal carcinoma cells |
| Q39392171 | Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation |
| Q34076405 | Protein mislocalization: mechanisms, functions and clinical applications in cancer |
| Q47110047 | Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer |
| Q38030982 | RNAi-mediated gene silencing in cancer therapy |
| Q37588022 | Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin |
| Q46256712 | Silencing of NAC1 Expression Induces Cancer Cells Oxidative Stress in Hypoxia and Potentiates the Therapeutic Activity of Elesclomol |
| Q37392963 | Synergistic effect between cisplatin and sunitinib malate on human urinary bladder-cancer cell lines. |
| Q99634863 | The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response |
| Q92230700 | The Role of Autophagy in Cancer |
| Q39289967 | The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. |
| Q92487257 | Transcriptional regulation of autophagy-lysosomal pathway in cancer |
| Q36726132 | YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells |
| Q38820618 | miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6. |